Apellis Pharmaceuticals, Inc. (APLS)
22.47
+0.19
(+0.85%)
USD |
NASDAQ |
Feb 23, 16:00
22.49
+0.02
(+0.09%)
After-Hours: 19:59
Apellis Pharmaceuticals Market Cap : 2.843B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amneal Pharmaceuticals, Inc. | 4.533B |
| Alnylam Pharmaceuticals, Inc. | 43.68B |
| Amicus Therapeutics, Inc. | 4.505B |
| Ionis Pharmaceuticals, Inc. | 13.70B |
| Sarepta Therapeutics, Inc. | 1.899B |
Market Cap Related Metrics
| PE Ratio | 75.66 |
| PS Ratio | 2.797 |
| Price to Book Value | 7.087 |
| Price to Free Cash Flow | 36.15 |
| Price | 22.47 |
| Earnings Yield | 1.32% |
| Operating PE Ratio | 35.36 |
| Normalized PE Ratio | 75.68 |